Clinical Epidemiology and Global Health,
Journal Year:
2022,
Volume and Issue:
17, P. 101144 - 101144
Published: Sept. 1, 2022
COVID
pandemic
has
massively
hit
every
nook
of
the
world.
Millions
people
were
infected
and
lost
their
lives
to
deadly
pandemic.
This
novel
virus
destroyed
essential
healthcare
service
globally.
Mass
vaccination
is
only
option
halt
transmission.
study
aimed
estimate
acceptance
vaccine
among
pregnant
women
breastfeeding
mothers.
BMJ,
Journal Year:
2022,
Volume and Issue:
unknown, P. e069741 - e069741
Published: Aug. 10, 2022
ABSTRACT
Pregnancy
is
an
independent
risk
factor
for
severe
covid-19.
Vaccination
the
best
way
to
reduce
SARS-CoV-2
infection
and
limit
its
morbidity
mortality.
The
current
recommendations
from
World
Health
Organization,
Centers
Disease
Control
Prevention,
professional
organizations
are
pregnant,
postpartum,
lactating
women
receive
covid-19
vaccination.
specific
considerations
involve
potential
effects
of
vaccination
on
fetal
development,
placental
transfer
antibodies,
safety
maternal
Although
pregnancy
was
exclusion
criterion
in
initial
clinical
trials
vaccines,
observational
data
have
been
rapidly
accumulating
thus
far
confirm
that
benefits
outweigh
risks.
This
review
examines
evidence
supporting
effectiveness,
immunogenicity,
transfer,
side
effects,
perinatal
outcomes
Additionally,
it
describes
factors
associated
with
vaccine
hesitancy
pregnancy.
Overall,
studies
monitoring
people
who
received
vaccines
during
not
identified
any
concerns.
Additional
information
non-mRNA
early
pregnancy,
longer
term
infants
needed.
To
collect
this
information,
must
be
prioritized
research.
Frontiers in Public Health,
Journal Year:
2022,
Volume and Issue:
10
Published: Oct. 3, 2022
Pregnant
women,
especially
those
with
comorbidities,
compared
to
non-pregnant,
have
higher
risk
of
developing
a
severe
form
COVID-19.
However,
COVID-19
vaccine
uptake
is
very
low
among
them.An
anonymous
questionnaire
was
administered
randomly
selected
women
18
years
age
that
were
currently
pregnant
or
had
just
given
birth
between
September
2021
and
May
2022
in
the
geographic
area
Naples.
Vaccine
hesitancy
assessed
using
scale
(VHS).A
total
385
participated.
Women
who
not
been
infected
by
SARS-CoV-2
needed
information
about
vaccination
against
perceived
being
SARS-CoV-2.
More
than
half
(54.3%)
afraid
potential
side
effects
on
fetus.
There
concern
fetus
did
graduate
degree,
high-risk
pregnancy,
SARS-CoV-2,
more
concerned
they
could
be
know
this
recommended
for
them,
trusting
mass
media/internet/social
networks
information.
Only
21.3%
vaccinated
when
pregnant,
mostly
university
before
need
information,
acquired
from
gynecologists.
Almost
three-quarters
(71.9%)
willing
receive
likely
at
least
one
relative/cohabitant
partner/friend
extremely
A
86.4%
highly
hesitant.
Highly
hesitant
respondents
get
less
information.Public
health
efforts
education
campaigns
are
changing
their
perception
patterns
supporting
gynecologists
promoting
vaccination.
BMJ Open,
Journal Year:
2023,
Volume and Issue:
13(2), P. e066367 - e066367
Published: Feb. 1, 2023
Background
Pregnant
women,
foetuses
and
infants
are
at
risk
of
infectious
disease-related
complications.
Maternal
vaccination
is
a
strategy
developed
to
better
protect
pregnant
women
their
offspring
against
morbidity
mortality.
Vaccines
influenza,
pertussis
recently
also
COVID-19
widely
recommended
for
women.
Yet,
there
still
significant
amount
hesitation
towards
maternal
policies.
Furthermore,
contradictory
messages
circulating
social
media
impact
vaccine
confidence.
Objectives
This
scoping
review
aims
reveal
how
impacted
confidence
in
lactating
Additionally,
this
studied
the
role
plays
creating
opinions
these
target
groups.
Eligibility
criteria
Articles
published
between
23
November
2018
18
July
2022
that
linked
objectives
were
included.
Reviews,
articles
not
focusing
on
group,
abstracts,
describing
outcomes
infection/COVID-19
excluded.
Sources
evidence
The
PubMed
database
was
searched
select
articles.
Search
terms
used
pregnancy,
lactation,
vaccination,
hesitancy,
media.
Charting
methods
Included
abstracted
synthesised
by
one
reviewer.
Verification
done
second
Disagreements
addressed
through
discussion
reviewers
other
researchers.
Results
generally
less
likely
accept
compared
with
non-pregnant
non-nursing
main
reason
refuse
safety
concerns.
A
positive
link
detected
willingness
acceptance
vaccines
during
pregnancy.
internet
identified
as
important
information
sources
vaccination.
Discussion
conclusion
Vaccine
hesitancy
remains
an
issue,
expressing
need
effective
interventions
increase
coverage.
uptake
unclear.
Human Reproduction,
Journal Year:
2023,
Volume and Issue:
38(5), P. 840 - 852
Published: Feb. 16, 2023
Abstract
STUDY
QUESTION
What
is
the
risk
of
miscarriage
among
pregnant
women
who
received
any
COVID-19
vaccines?
SUMMARY
ANSWER
There
no
evidence
that
vaccines
are
associated
with
an
increased
miscarriage.
WHAT
IS
KNOWN
ALREADY
In
response
to
pandemic,
mass
roll-out
helped
boost
herd
immunity
and
reduced
hospital
admissions,
morbidity,
mortality.
Still,
many
were
concerned
about
safety
for
pregnancy,
which
may
have
limited
their
uptake
those
planning
a
pregnancy.
DESIGN,
SIZE,
DURATION
For
this
systematic
review
meta-analysis,
we
searched
MEDLINE,
EMBASE,
Cochrane
CENTRAL
from
inception
until
June
2022
using
combination
keywords
MeSH
terms.
PARTICIPANTS/MATERIALS,
SETTING,
METHODS
We
included
observational
interventional
studies
enrolled
evaluated
available
compared
placebo
or
vaccination.
primarily
reported
on
in
addition
ongoing
pregnancy
and/or
live
birth.
MAIN
RESULTS
AND
THE
ROLE
OF
CHANCE
data
21
(5
randomized
trials
16
studies)
reporting
149
685
women.
The
pooled
rate
vaccine
was
9%
(n
=
14
749/123
185,
95%
CI
0.05–0.14).
Compared
vaccination,
did
not
higher
(risk
ratio
(RR)
1.07,
0.89–1.28,
I2
35.8%)
had
comparable
rates
birth
(RR
1.00,
0.97–1.03,
10.72%).
LIMITATIONS,
REASONS
FOR
CAUTION
Our
analysis
varied
reporting,
high
heterogeneity
bias
across
studies,
limit
generalizability
confidence
our
findings.
WIDER
IMPLICATIONS
FINDINGS
increase
reproductive
age.
current
remains
larger
population
needed
further
evaluate
effectiveness
vaccination
FUNDING/COMPETING
INTEREST(S)
No
direct
funding
provided
support
work.
M.P.R.
funded
by
Medical
Research
Council
Centre
Reproductive
Health
Grant
No:
MR/N022556/1.
B.H.A.W.
hold
personal
development
award
National
Institute
UK.
All
authors
declare
conflict
interest.
REGISTRATION
NUMBER
CRD42021289098.
SAS Journal of Medicine,
Journal Year:
2024,
Volume and Issue:
10(01), P. 9 - 19
Published: Jan. 2, 2024
Introduction:
COVID-19
vaccines
are
essential
in
reducing
symptoms
and
severity
of
the
disease
as
well
preventing
infection
with
COVID-19.
Vaccination
pregnant
women
against
has
been
recommended
globally.
In
Zambia,
there
is
a
paucity
information
on
knowledge,
attitude,
acceptance,
perceived
risks
among
women.
Therefore,
this
study
assessed
vaccination
attending
antenatal
care
at
Women
Newborn
Hospital
(WNH)
University
Teaching
Hospitals
(UTHs)
Lusaka,
Zambia.
Methods:
This
was
descriptive
cross-sectional
conducted
from
August
2023
to
October
300
Data
were
collected
using
structured
questionnaire
analysed
Statistical
Package
for
Social
Science
(SPSS)
version
23.0.
The
Chi-square
test
used
relationship
between
dependent
independent
variables.
statistical
significance
95%
confidence
level.
Results:
Of
participants,
186
(62.0%)
aged
24
34
years
185
(61.5%)
aware
that
vaccine
pregnancy.
Overall,
284
(94.7%)
had
good
258
(86.0%)
positive
vaccinated.
Additionally,
20
(17.5%)
who
not
vaccinated
willing
be
Furthermore,
most
participants
felt
safe
use
results
show
lower
acceptance
compared
knowledge
attitude
levels.
Having
associated
education
status
(X^2=33.011,
p=0.001
level)
(X^2=9.132,
p=0.029
level).
Conclusion:
found
WNH
attitudes,
perceptions,
high
..........
npj Vaccines,
Journal Year:
2024,
Volume and Issue:
9(1)
Published: July 20, 2024
Abstract
Uptake
of
the
COVID-19
vaccine
among
pregnant
persons
is
lower
than
general
population.
This
scoping
review
explored
people’s
attitudes
towards
vaccine,
reasons
for
hesitancy,
and
whether
about
vaccines
differ
by
country
origin.
A
was
conducted
across
PubMed,
Embase,
CINHAL,
Scopus.
Inclusion
criteria
were
articles
published
in
English
from
2019–2022
focused
on
vaccination
persons.
Data
analysis
done
via
5Cs
framework
hesitancy:
Constraints,
Complacency,
Calculation,
Confidence,
Collective
Responsibility.
44
extracted.
lack
confidence
safety
most
prevalent
theme
hesitancy
largely
driven
a
access
to
information
as
well
mistrust
medical
professionals.
Meanwhile,
acceptance
mostly
desire
protect
themselves
their
loved
ones.
Overall,
continues
be
high.
Vaccine
primarily
fear
unknown
side
effects
fetuses
along
with
mistrust.
Some
differences
can
seen
between
high
income
low-
middle-income
countries
regarding
showing
that
single
solution
cannot
applied
all
who
are
hesitant.
General
strategies,
however,
utilized
reduce
including
advocating
inclusion
clinical
trials
incorporating
consistent
counseling
during
prenatal
appointments.
BMJ Open,
Journal Year:
2023,
Volume and Issue:
13(2), P. e065901 - e065901
Published: Feb. 1, 2023
The
discovery
and
subsequent
manufacture
of
various
types
COVID-19
vaccines
were
considered
a
breakthrough
in
the
fight
against
pandemic.
Initially,
limited
supplies
warranted
vulnerable
populations
such
as
people
living
with
chronic
non-communicable
diseases
elderly
to
be
prioritised
for
vaccination.
Nevertheless,
uptake
among
these
was
suboptimal.
In
this
study,
we
aimed
describe
drivers
vaccine
hesitancy
Ibadan,
Nigeria.We
applied
qualitative
methods
explore
feelings
thoughts
towards
vaccines,
at
tertiary
hospital
Nigeria.
Data
obtained
from
25
conditions
through
in-depth
interviews.
We
thematically
analysed
transcripts
inductively
deductively.
Dedoose
data
management
software
used
manage
data.Emerging
subthemes
grouped
into
two
major
themes:
Hesitancy
related
biological
concerns
those
sociopolitical
issues.
associated
factors
included:
(1)
over
worsening
underlying
condition;
(2)
fear
harmful
physiological
consequences;
(3)
insufficient
testing
safety
(4)
perceived
infectiveness.
Sociopolitical
misconceptions
treatment
COVID-19;
mistrust
manufacturers
('the
whites');
government
misinformation.Public
health
education
on
nature
benefits
is
urgently
needed
diseases.
These
measures
could
improve
healthcare
usage
general.
Paying
attention
have
implications
next
global
pandemic
requiring
mass
Human Vaccines & Immunotherapeutics,
Journal Year:
2025,
Volume and Issue:
21(1)
Published: Jan. 11, 2025
The
attitudes
of
reproductive-age
individuals
toward
COVID-19
vaccination
during
pregnancy
are
still
not
well
understood.
We
aimed
to
explore
the
vaccines
and
determinants
among
Chinese
population.
An
anonymous
cross-sectional
study
was
conducted
in
China
from
July
4
August
11,
2023.
Structured
questionnaires
on
vaccine
hesitancy
pregnancy,
socio-demographic
characteristics,
behavior
health-related
factors,
mental
health
status
were
sent
online
(both
males
females).
Among
2966
participants
reproductive
age,
86.9%
exhibited
significant
receiving
pregnancy.
Participants
older
age
(30–34:
aOR
=
1.71,
95%
CI:
1.62–2.52;
35–39:
1.72,
1.11–2.66),
nonsmokers
(aOR
1.42,
1.07–1.89),
with
a
longer
duration
since
their
last
2.37,
1.20–4.70),
exhibiting
marked
pandemic
fatigue
(moderate:
1.98,
1.56–2.52;
high:
3.49,
2.41–5.05)
prone
refuse
presence
generalized
anxiety
disorder
may
push
0.75,
0.57–0.99).
top
three
reasons
for
hesitation
concerns
about
adverse
effects
pregnant
women
(77.72%),
fetuses
(72.13%),
newborns/infants
(58.77%),
respectively.
Therefore,
under
context
existing
circumstances
WHO's
encouragement,
this
provides
data
support
possible
future
policy
changes
emphasizes
importance
public
strategies.
Vaccine,
Journal Year:
2025,
Volume and Issue:
53, P. 127070 - 127070
Published: April 1, 2025
Pregnant
women
are
at
an
elevated
risk
for
severe
COVID-19,
but
nationwide
rates
of
vaccination
and
its
timing
during
pregnancy
not
well
documented
in
France.
To
assess
COVID-19
among
pregnant
France,
compare
them
to
those
the
general
population,
analyse
factors
associated
with
status
timing.
A
study
using
EPI-MERES
register,
which
includes
all
1,203,454
who
delivered
between
April
2021
December
2022
Standardization
by
age
social
index
was
used
female
population.
Associations
sociodemographic
factors,
monitoring
indicators,
pre-existing
comorbidities
were
measured
multivariable
logistic
regression.
Overall,
52
%
received
least
one
vaccine
dose,
62.1
vaccinated
before
conception
8.2
%,
20.9
8.8
1st,
2nd,
3rd
trimester,
respectively.
Vaccination
initially
lagged
behind
population
converged
June
2022,
a
six-month
lag.
Younger
more
socially
deprived
less
highly
vaccinated.
Unvaccinated
likely
be
their
third
(aOR,
1.21
[1.19-1.22]),
had
fewer
ultrasound
scans
0.71
[0;
70-0.73]),
often
took
folic
acid
0.73
[0.72-0.74]).
Women
comorbidities,
such
as
obesity,
diabetes,
hypertension,
antidepressant
use,
or
chronic
respiratory
disease,
unvaccinated
(aORs
ranged
from
0.69
0.89).
France
than
crucial
pandemic
periods
eventually
reached
similar
rates.
Socioeconomic
level
prenatal
care
strongly
low
uptake.
This
should
focus
future
interventions
policy
adjustments
across
segments
this